
Equities gain ahead of Fed policy announcement
The FTSE rebounded by 0.9% on Wednesday after tanking 0.9% in the previous session. GSK led the charge higher on M&A news, whilst strength on Wall Street was also helping the cause.
Share this:

The FTSE rebounded by 0.9% on Wednesday after tanking 1.1% in the previous session. GSK led the charge higher on M&A news, whilst strength on Wall Street was also helping the cause.
GSK rallies on Pfizer deal
GSK surged to a session high of 1567p following an announcement that it will merge healthcare business with Pfizer to make a £10 billion consumer drugs giant. GSK shareholders cheered the news after pressing the firm for years to take action. It has long been the assumption that the two businesses in GSK, over the counter medicine and the other focusing on researching pharmaceuticals and vaccines would perform better as two separate companies rather than one diversified group.
Pound strengthens despite no deal Brexit planning
The pound experienced another choppy session. Sterling picked itself up from session lows and moved back into the black versus the dollar. However, that was more of a dollar weakness story than a flip in sentiment towards the pound.
As no deal Brexit planning is being ramped up in both the UK and the EU, pound traders are increasingly nervous that this could actually all go horribly wrong. Trading at $1.2650 the pound is by no means pricing in a no deal Brexit, nerves are building. Adding to the strains of the pound was UK consumer inflation data. Whilst in line with expectations, UK CPI fell to its lowest level in 20 months. This is good news for the UK consumer, it pushes back the chances of the BoE hiking rates.
The euro was outperforming its peers on Wednesday. In sharp contrast to the UK’s weak data and Brexit woes; German PPI surprised to the upside, eurozone trade data impressed and Italian political fears are fading. As a result, the euro, rallied.
Dollar Lower, Wall Street Higher ahead of Fed
The dollar was trading lower and Wall Street higher as investors looked cautiously ahead to the Fed’s policy announcement later this evening. The Fed is widely expected to hike rates by 25 basis points for a fourth time this year, despite criticism from Trump.
With the hike well priced in the investors will be looking closely at what the Fed has instore for next year. We are expecting a dovish hike from the Fed, with the well-used phrase “gradual further hikes” to be dropped from the statement. Furthermore, we expect the Fed to trim is forecast of further hikes. The Fed will have to strike a balance between addressing the current strength in the economy (GDP 3.5% yoy Q3) and taking onboard signs of a slowing global economy. Additionally, they will need to do this in such a way that it doesn’t alarm financial markets. The fact that US equity indices are moving higher again today shows that the traders are expecting the Fed’s message to soothe volatile markets.
Latest market news
View more newsOpen an account today
Experience award-winning platforms with fast and secure execution.
Economic calendar
Web Trader platform
Our sophisticated web-based platform is packed with features.

What UK GDP Means for GBP/AUD After a Key Resistance Break
The GBP/AUD breakout follows a Reserve Bank of Australia rate hike paired with a signal of a prolonged pause, draining support from the Aussie.

Pound forecast: GBP/USD and GBP/AUD in focus ahead of UK GDP
The GBP/USD fell below the 1.33 handle today as the dollar gained further ground against most major currencies. The GBP has remained supported against other currencies, thanks to a hawkish BoE and high UK interest rates.

EUR/USD Analysis: U.S. Inflation Data Keeps Pressure on the Euro
The trading week continues to unfold and the latest session has once again highlighted weakness around the euro against the U.S. dollar. EUR/USD is down nearly 0.3%, reflecting that the European currency continues to struggle to sustain a consistent recovery in the short term.
From time to time, StoneX Financial Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.
As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.






